Clinical Trial

Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.

Recruiting
View on ClinicalTrials.gov →
Summary
To describe the peripheral serum levels of the anti-inflammatory cytokines IL-4 (Interleukin-4), IL-10 (Interleukin-10), TGF-ß1 (Transforming Growth Factor beta1), the pro-inflammatory cytokines IL-17 (Interleukin-17), IFγ (Interferon Gamma) and the immune mediator PIBF (Progesterone-Induced Blocking Factor) along a single frozen euploid blastocyst transfer in a natural cycle (NC) or Hormone Replacement Therapy (HRT).
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-07-22; most recent amendment 2026-06-22.
Status change: Not Yet Recruiting → Recruiting 2023-07-19
Status change: Recruiting → Not Yet Recruiting 2023-02-01
Status change: Not Yet Recruiting → Recruiting 2022-11-06
Trial Details
NCT Number NCT05473273
Lead Sponsor ART Fertility Clinics LLC
Conditions Infertility, Female
Enrollment 40 participants
Start Date 2023-04-24
Primary Completion 2026-12-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-25